Prostate cancer
Results
Phase 3
This trial looked at enzalutamide and radium 223 for prostate cancer that had continued to grow despite hormone therapy. It was for men whose cancer had spread to their bones.
People could join the trial between 2015 and 2023. The team published the results in 2025.
Recruitment start: 1 November 2015
Recruitment end: 31 March 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Santhanam Sundar
Astellas Pharma
Bayer Pharma AG
European Organization for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 19 Jun 2026
CRUK internal database number: 13877
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
